Skip to content

MoonLake Immunotherapeutics

MLTX· NasdaqCore metricsCIK 1821586

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -4.70%
Market cap
$1.10B
85.11M shares
Filings
331
—
—
—
-$79.55M
Q3 2026N/M FY25 yoy
-$79.85M
Q3 2026N/M FY25 yoy
-$185.25M
Q3 2026derivedN/M FY25 yoy
-$0.93
Q3 2026N/M FY25 yoy
$379.70M
Q3 2026+85.4% FY25 yoy
$1.10B
—
—
2.9×
-17.90%
—

FY2025 figures · derived

Price

$12.87+9.63%+$1.13past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$202.86MFY 2025
$202.86M0FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$202,862,000reported
FY 20242024-12-31$112,771,000reported
FY 20232023-12-31$31,802,000reported
FY 20222022-12-31$42,048,954reported

Capital returns

Dividends and buybacks · FY2022 to FY2024
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2024—$50.00$50.00————
FY2023—$0.00$0.00————
FY2022—$0.00$0.00————

Segments

Geography
Long-lived assets by Geography, FY2022 to FY2025FY2022Switzerland · FY2022 · $331.97KFY2023Portugal · FY2023 · $737.40KUnited Kingdom · FY2023 · $2.70MSwitzerland · FY2023 · $507.39KFY2024Portugal · FY2024 · $1.26MUnited Kingdom · FY2024 · $1.78MSwitzerland · FY2024 · $610.00KFY2025Portugal · FY2025 · $1.02MUnited Kingdom · FY2025 · $804.00KSwitzerland · FY2025 · $322.00K
LineFY2025ShareChange
Portugal$1.02M47%−19.1%
United Kingdom$804.00K38%−54.8%
Switzerland$322.00K15%−47.2%
United States$0.00——
Total$2.14M

From the 10-Q filed Nov 4, 2026MLTX

Pharmaceutical preparations

MoonLake Immunotherapeutics is the 141st largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

MoonLake Immunotherapeutics · CIK 1821586 · Engraved from SEC EDGAR